Cardiovascular Systems Inc. (CSII) Hits New 52-Week High at $25.00
Cardiovascular Systems Inc. (NASDAQ:CSII) shares reached a new 52-week high on Tuesday . The company traded as high as $25.00 and last traded at $24.66, with a volume of 101,633 shares trading hands. The stock had previously closed at $24.88.
A number of research analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $24.00 target price on the stock in a research note on Monday, August 8th. Bank of America Corp. upgraded shares of Cardiovascular Systems from an “underperform” rating to a “neutral” rating in a research note on Thursday, August 4th. Needham & Company LLC lifted their target price on shares of Cardiovascular Systems from $23.00 to $27.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Finally, Leerink Swann upgraded shares of Cardiovascular Systems from a “market perform” rating to an “outperform” rating and set a $30.00 target price on the stock in a research note on Monday, August 22nd. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Cardiovascular Systems currently has a consensus rating of “Buy” and a consensus price target of $23.71.
The firm’s market cap is $799.61 million. The firm has a 50 day moving average price of $21.27 and a 200-day moving average price of $15.81.
Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings data on Wednesday, August 3rd. The medical device company reported ($0.15) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.20) by $0.05. The business earned $48.50 million during the quarter, compared to analyst estimates of $46.01 million. During the same quarter in the previous year, the company earned ($0.27) EPS. The firm’s revenue was up .0% compared to the same quarter last year. Analysts anticipate that Cardiovascular Systems Inc. will post ($0.62) earnings per share for the current year.
In other news, CFO Laurence L. Betterley sold 3,568 shares of the stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $23.96, for a total value of $85,489.28. Following the sale, the chief financial officer now owns 253,031 shares in the company, valued at $6,062,622.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Paul A. Koehn sold 4,000 shares of the stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $22.17, for a total transaction of $88,680.00. Following the completion of the sale, the senior vice president now owns 102,652 shares in the company, valued at approximately $2,275,794.84. The disclosure for this sale can be found here.
A hedge fund recently raised its stake in Cardiovascular Systems stock. Schwab Charles Investment Management Inc. boosted its position in Cardiovascular Systems Inc. (NASDAQ:CSII) by 3.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 98,841 shares of the medical device company’s stock after buying an additional 2,932 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.30% of Cardiovascular Systems worth $1,495,000 at the end of the most recent reporting period.
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.